Baxter

YTD

ALL

Trade Baxter 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BAX

Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom.

CEO

D. Brent Shafer

CEOD. Brent Shafer

Employees

38,000

Employees38,000

Headquarters

Deerfield, Illinois

HeadquartersDeerfield, Illinois

Founded

1931

Founded1931

Employees

38,000

Employees38,000

BAX Key Statistics

Market cap

14.17B

Market cap14.17B

Price-Earnings ratio

-71.69

Price-Earnings ratio-71.69

Dividend yield

3.64%

Dividend yield3.64%

Average volume

11.80M

Average volume11.80M

High today

$22.36

High today$22.36

Low today

$21.33

Low today$21.33

Open price

$21.50

Open price$21.50

Volume

22.65M

Volume22.65M

52 Week high

$40.49

52 Week high$40.49

52 Week low

$21.33

52 Week low$21.33

BAX News

Seeking Alpha 17h

Baxter cut to Neutral at Goldman Sachs after Q2 miss

Goldman Sachs has downgraded Baxter International (NYSE:BAX) to Neutral from Buy and trimmed its 12-month price target to $25 from $37 after the healthcare prod...

Seeking Alpha 2d

Baxter slumps as Medical Products & Therapies drive Q2 revenue miss

Baxter International (NYSE:BAX) lost ~21% in the morning hours on Thursday to reach a new 52-week low as the healthcare product manufacturer fell short of the c...

Analyst ratings

65%

of 20 ratings

Buy

25%

Hold

65%

Sell

10%

People also own

Based on the portfolios of people who own BAX. This list is generated using Robinhood data, and it’s not a recommendation.